Aldeyra Therapeutics (ALDX) Reports Q1 Loss of $0.58/Share
Tweet
Share
E-mailGet Alerts ALDX Hot Sheet
Join SI Premium – FREE
Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.58), versus ($0.43) reported last year.
For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Hewlett Packard Enterprise (HPE) Tops Q3 EPS by 19c; raises guidance
- Five Below raises full-year outlook after strong second-quarter sales growth
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
